Hypofractionated vs. conventional radiation therapy for stage III non-small cell lung cancer treated without chemotherapy-Reference-Cited by-同舟云学术

Hypofractionated vs. conventional radiation therapy for stage III non-small cell lung cancer treated without chemotherapy

Published:2019-10-12 Issue:2 Volume:59 Page:164-170
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Iocolano Michelle¹,Wild Aaron T.²,Hannum Margaret³,Zhang Zhigang³,Simone Charles B.²,Gelblum Daphna²,Wu Abraham J.²,Rimner Andreas²,Shepherd Annemarie F.²

Affiliation:

1. Stony Brook University School of Medicine, Stony Brook, NY, USA;

2. Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA;

3. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2019.1675907

Reference25 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410

3. Improved Survival in Stage III Non-Small-Cell Lung Cancer: Seven-Year Follow-up of Cancer and Leukemia Group B (CALGB) 8433 Trial

4. Radiotherapy for lung cancer in the elderly

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lymphocyte radiosensitivity: An extension to the linear-quadratic model?;Radiotherapy and Oncology;2024-09

2. Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 2. Lung (non-small cell lung cancer);Radiation Oncology Journal;2024-06-30

3. Efficiency of moderately hypofractionated radiotherapy in NSCLC cell model;Frontiers in Oncology;2024-04-24

4. Prognostic Value of Metabolic Tumor Volume for Locally Advanced Non-Small Cell Lung Cancer Patients Treated with Definitive Radiotherapy without Chemotherapy: A Modern Experience;2023-11-10

5. Consensus Quality Measures and Dose Constraints for Lung Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and ASTRO Expert Panel;Practical Radiation Oncology;2023-09